Identification of RHEX as a novel biomarker related to progression and immunity of non-small cell lung carcinoma

BACKGROUND: The therapeutic response and prognosis of patients with non-small cell lung carcinoma (NSCLC) are widely related to immunity. To improve the prognosis of patients and provide reliable information to guide appropriate personalized treatment strategies, it is necessary to identify reliable...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tao, Dai, Tianyang, Zeng, Peiyuan, Song, Qi, He, Kaiming, Hu, Zhi, Li, Yuan, Li, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797495/
https://www.ncbi.nlm.nih.gov/pubmed/35116680
http://dx.doi.org/10.21037/tcr-21-1316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797495/
https://www.ncbi.nlm.nih.gov/pubmed/35116680
http://dx.doi.org/10.21037/tcr-21-1316

Ejemplares similares